PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Description

The standard of care imaging of prostate cancer metastases recommended by the National Comprehensive Cancer Network (NCCN), CT of the chest/abdomen/pelvis and bone scan, may be suboptimal. PyL is a novel PET tracer designed to detect prostate specific membrane antigen (PSMA) expressed on prostate cancer cells. PyL PET/CT may provide improved evaluation of clinically significant metastases in patients with prostate cancer.

Conditions

Prostate Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The standard of care imaging of prostate cancer metastases recommended by the National Comprehensive Cancer Network (NCCN), CT of the chest/abdomen/pelvis and bone scan, may be suboptimal. PyL is a novel PET tracer designed to detect prostate specific membrane antigen (PSMA) expressed on prostate cancer cells. PyL PET/CT may provide improved evaluation of clinically significant metastases in patients with prostate cancer.

2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (PyL) in Patients With High Risk and Biochemically Recurrent Prostate Cancer

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

Irvine

Hoag Memorial Hospital Presbyterian, Irvine, California, United States, 92618

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Male ≥ 18 years of age.
  • 2. Histologically confirmed adenocarcinoma of the prostate
  • 3. Patients meet one of the follow criteria:
  • 1. Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  • 2. Patients who cannot undergo PET/CT scanning because of weight limits. PET/CT scanners may not be able to function with patients over 450 pounds.
  • 3. Change in therapy since standard of care imaging

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Hoag Memorial Hospital Presbyterian,

Deborah Fridman, PsyD, RN, STUDY_DIRECTOR, Hoag Memorial Hospital Presbyterian

Study Record Dates

2022-12-15